Myoadenylate deaminase deficiency digital illustration

Myoadenylate deaminase deficiency Save


ICD-10 code: E79.2

Disease category: E79: Disorders of purine and pyrimidine metabolism

Understanding Myoadenylate Deaminase Deficiency

Myoadenylate deaminase deficiency (MADD) is a genetic disorder that affects the muscles. It is also known as AMP deaminase deficiency and is caused by a lack of the enzyme myoadenylate deaminase (MAD) in the muscle cells. The enzyme is responsible for breaking down adenosine monophosphate (AMP), a molecule that provides energy to the muscles during exercise. Without MAD, the muscles are unable to efficiently break down AMP, leading to muscle weakness and fatigue.

MADD is a rare condition, and its prevalence is estimated to be around 1 in 100,000 people. It can affect individuals of any age and gender, but it is most commonly diagnosed in adults.

  1. Symptoms: The symptoms of MADD can vary widely between individuals. Some people may experience muscle pain, weakness, and fatigue during exercise, while others may not experience any symptoms at all. In severe cases, MADD can lead to muscle damage and breakdown, resulting in rhabdomyolysis, a serious condition that can cause kidney damage.
  2. Diagnosis: MADD can be diagnosed through a blood test that measures the levels of MAD enzyme in the muscle cells. Genetic testing may also be used to confirm the diagnosis.
  3. Causes: MADD is caused by mutations in the AMPD1 gene, which provides instructions for making the MAD enzyme. These mutations can result in a decrease or complete absence of the enzyme, leading to the symptoms of MADD.
  4. Treatment: Currently, there is no cure for MADD. However, the symptoms can be managed through lifestyle changes such as avoiding strenuous exercise and following a low purine diet. Physical therapy may also be recommended to improve muscle strength and function.

If you suspect that you or a loved one may have MADD, it is important to seek medical advice. A healthcare professional can perform the necessary tests to diagnose the condition and provide guidance on managing the symptoms.

Overall, while MADD can be a challenging condition to live with, proper management can help individuals lead a normal life. With the right care and support, individuals with MADD can continue to participate in daily activities and maintain a high quality of life.

Treatment of Myoadenylate deaminase deficiency:

Treatment options for Myoadenylate deaminase deficiency (MADD)

Myoadenylate deaminase deficiency (MADD) is a rare genetic disorder that affects the muscles. It occurs when the body doesn't produce enough myoadenylate deaminase, an enzyme that helps break down adenosine monophosphate (AMP) during exercise. This results in muscle pain, cramps, and weakness. While there is no cure for...

To see full information about treatment please Sign up or Log in